Drug intelligence / Profile preview

i-fresh GEL

Development stage: Unknown
Lead developer: DÁVI
Modality: Small Molecules
Administration: Ophthalmic

Overview

i-fresh GEL is an ophthalmic topical formulation developed and marketed by the Portuguese pharmaceutical company DÁVI. It is a combination product containing 5% dexpanthenol and 0.3% carbomer, designed to treat symptoms of dry eye and related ocular discomfort. Carbomer acts as a viscosity-increasing agent that forms a stable, lubricating, and moisturizing film over the ocular surface, providing long-lasting relief from dryness, burning, and foreign body sensations. Dexpanthenol, a provitamin of B5, serves as a moisturizing and healing agent that supports the regeneration of the corneal epithelium. The product is particularly indicated for ocular fatigue and irritation caused by environmental factors such as prolonged computer use, air conditioning, or heating.

Brand names: i-fresh GEL

Beyond the preview

Go deeper on i-fresh GEL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-fresh GEL.

Explore the full profile